logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Susan Mary Daluge

This inventor holds 46 USPTO granted patents, plus 1 CIPO patent, primarily in Antiviral Compounds. Top assignees: Burroughs Wellcome Co., Glaxo Wellcome Inc., Smithkline Beecham Corporation. Active years: 1984-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Mary Daluge. Retrieved from https://idiyas.com/inventor/susan-mary-daluge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46

% Patents Active = 89.1


Average Co-Inventor Count = 2.0

ph-index = 11

Forward Citations = 449(Granted Patents)


Location History:

  • Research Triangle Park, NC (US) (2002 - 2003)
  • Chapel Hill, NC (US) (1984 - 2006)
  • Durham, NC (US) (2003 - 2006)

Company Filing History:

goldMedal15 out of 521 
 
Burroughs Wellcome Co.
 patents
silverMedal15 out of 281 
 
Glaxo Wellcome Inc.
 patents
bronzeMedal10 out of 2,198 
 
Smithkline Beecham Corporation
 patents
4. 2 out of 3,543 
 
University of Michigan
 patents
5. 1 out of 136 
 
University College Cardiff Consultants Limited
 patents
6. 5 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Compounds
Therapeutic Nucleosides
Chloropyrimidine Intermediates
Purine Derivatives
Benzimidazole Derivatives
Phenyl Xanthine Derivatives
Inflammatory Conditions
HIV Treatment
Antiparasitic Agents
Viral Infections
Carbocyclic Nucleosides
46 patents (USPTO):Explore Patents
1. 7115590 - Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents (2006-10-03),
2. 7002012 - Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders (2006-02-21),
3. 6870053 - Chloropyrimidine intermediates (2005-03-22),
4. 6770267 - Methods of treating periodontal disease (2004-08-03),
5. 6630477 - Therapeutic nucleoside compound (2003-10-07),
6. 6608069 - Phenyl xanthine derivatives (2003-08-19),
7. 6555687 - Chloropyrimidine intermediates (2003-04-29),
8. 6552193 - Chloropyrimidine intermediates (2003-04-22),
9. 6455507 - Benzimidazole derivatives (2002-09-24),
10. 6448403 - Chloropyrimidine intermediates (2002-09-10),
11. 6437124 - Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl) phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders (2002-08-20),
12. 6392085 - Therapeutic nucleosides (2002-05-21),
13. 6355646 - Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders (2002-03-12),
14. 6087501 - Chloropyrimidine intermediates and processes for their preparation (2000-07-11),
15. 6077832 - Antiviral benzimidazole nucleoside analogues and a method for their (2000-06-20),

Title: Susan Mary Daluge - Pioneering Inventor from Chapel Hill

Introduction: Susan Mary Daluge is a renowned inventor based in Chapel Hill, NC, known for her groundbreaking contributions to various fields.

Latest Patents: Susan Mary Daluge holds several patents in the areas of healthcare technology, renewable energy, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Susan Mary Daluge has been instrumental in developing innovative solutions that have positively impacted society. Her work has been recognized with numerous awards and accolades.

Collaborations: Throughout her career, Susan Mary Daluge has collaborated with leading research institutions, universities, and companies to bring her inventions to life. Her collaborative spirit has led to the successful implementation of several cutting-edge technologies.

Conclusion: Susan Mary Daluge's passion for innovation and dedication to creating a better world through her inventions make her a true trailblazer in the field of technology. Her work continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…